Unique molecular characteristics of the environmental responses of mucosal macrophages

Anticancer Research

Volumn 26, Issue 6 A, 2006, Pages 4009-4014

  Nakata, Kazue ^a   Inagawa, Hiroyuki ^a,b,c   Nishizawa, Takashi ^a   Kohchi, Chie ^a,c   Taniguchi, Yoshie ^a   Yoshioka, Noriko ^a   Soma, Gen Ichiro ^a,c  

^a TOKUSHIMA BUNRI UNIVERSITY   (Japan)

^b NATIONAL FISHERIES UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CD14; Environmental response; Intestinal macrophages; LPS; Review

Indexed keywords

CD14 ANTIGEN; CYTOKINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4;

CELL COMMUNICATION; CELL INTERACTION; CELL MIGRATION; CELL STRUCTURE; ENVIRONMENTAL FACTOR; FOREIGN BODY; HOMEOSTASIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; MACROPHAGE; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; MUCOSA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; CELL COMMUNICATION; HOMEOSTASIS; HUMANS; INTESTINAL MUCOSA; MACROPHAGES; XENOBIOTICS;

EID: 33846016617     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Kohchi C, Inagawa H, Hino M, Oda M, Nakata K, Yoshida A, Hori H, Terada H, Makino K, Takiguchi K and Soma G: Utilization of macrophages in anticancer therapy: the macrophage network theory. Anticancer Res 24: 3311-3320, 2004.
2. Lewis CE and McGee JO: The Macrophage. Oxford, UK, Oxford University Press, 1992.
3. Andus TRG, Daig R, Falk W, Scholmerich J and Gross V: The role of macrophages. In: Inflammatory Bowel Disease. G. N. J. Tygat JFWB and S. J. H. van Deventer (eds.). Dordrecht, The Netherlands, Kluwer, pp. 281-297, 1995.
4. Laskin DL, Weinberger B and Laskin JD: Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 70: 163-170, 2001.
5. Leibovich SJ and Knyszynski A: In vitro recognition of "old" red blood cells by macrophages from syngeneic mice: characteristics of the macrophage-red blood cell interaction. J Reticuloendothel Soc 27: 411-419, 1980.
6. Johnston RB Jr: Current concepts: immunology. Monocytes and macrophages. N Engl J Med 318: 747-752, 1988.
7. Medzhitov R and Janeway CA Jr: Decoding the patterns of self and nonself by the innate immune system. Science 296: 298-300, 2002.
8. Hashimoto C, Hudson KL and Anderson KV: The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52: 269-279, 1988.
9. Lemaitre B, Nicolas E, Michaut L, Reichhart JM and Hoffmann JA: The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86: 973-983, 1996.
10. Akira S and Takeda K: Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004.
11. Takeda K and Akira S: Toll receptors and pathogen resistance. Cell Microbiol 5: 143-153, 2003.
12. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA and Ghosh S: A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526, 2004.
13. Medzhitov R, Preston-Hurlburt P and Janeway CA Jr: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397, 1997.
14. Nanno M, Kanamori Y, Saito H, Kawaguchi-Miyashita M, Shimada S and Ishikawa H: Intestinal intraepithelial T lymphocytes. Our T cell horizons are expanding. Immunol Res 18: 41-53, 1998.
15. Otte JM, Kiehne K and Herzig KH: Antimicrobial peptides in innate immunity of the human intestine. J Gastroenterol 38: 717-726, 2003.
16. Macpherson AJ, Geuking MB and McCoy KD: Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 115: 153-162, 2005.
17. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R and Corinaldesi R: Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 100: 2560-2568, 2005.
18. Dubois B, Goubier A, Joubert G and Kaiserlian D: Oral tolerance and regulation of mucosal immunity. Cell Mol Life Sci 62: 1322-1332, 2005.
19. Wittig BM and Zeitz M: The gut as an organ of immunology. Int J Colorectal Dis 18: 181-187, 2003.
20. Cario E: Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and NOD2. Gut 54: 1182-1193, 2005.
21. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
22. Dal Nogare AR: Septic shock. Am J Med Sci 302: 50-65, 1991.
23. Rangel-Frausto MS: The epidemiology of bacterial sepsis. Infect Dis Clin North Am 13: 299-312, vii, 1999.
24. Cario E and Podolsky DK: Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017, 2000.
25. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET and Arditi M: Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 767: 1609-1616, 2001.
26. Otte JM, Cario E and Podolsky DK: Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070, 2004.
27. Lee SH, Starkey PM and Gordon S: Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med 161: 475-489, 1985.
28. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM and Smith PD: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75, 2005.
29. Bull DM and Bookman MA: Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 59: 966-974, 1977.
30. Nakata K, Inagawa H, Nishizawa T, Honda T, Kohchi C, Tonomoto Y, Yoshimura H, Nagasue N, Natori S, Terada H and Soma GI: Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int J Colorectal Dis 1-9, 2005.
31. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P and Scott H: Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112: 1493-505, 1997.
32. Smith PD, Smythies LE, Mosteller-Barnum M, Sibley DA, Russell MW, Merger M, Sellers MT, Orenstein JM, Shimada T, Graham MF and Kubagawa H: Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 167: 2651-2656, 2001.
33. Smith PD, Janoff EN, Mosteller-Barnum M, Merger M, Orenstein JM, Kearney JF and Graham MF: Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine. J Immunol Methods 202: 1-11, 1997.
34. Smith PD, Meng G, Sellers MT, Rogers TS and Shaw GM: Biological parameters of HIV-1 infection in primary intestinal lymphocytes and macrophages. J Leukoc Biol 68: 360-365, 2000.
35. Schenk M, Bouchon A, Birrer S, Colonna M and Mueller C: Macrophages expressing triggering receptor expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol 174: 517-524, 2005.
36. Rogler G, Hausmann M, Vogl D, Aschenbrenner E, Andus T, Falk W, Andreesen R, Scholmerich J and Gross V: Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112: 205-215, 1998.
37. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, Stewart CL and Goyert SM: Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4: 407-414, 1996.
38. Moore KJ, Andersson LP, Ingalls RR, Monks BG, Li R, Arnaout MA, Golenbock DT and Freeman MW: Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J Immunol 765: 4272-4280, 2000.
39. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B and Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088, 1998.
40. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K and Akira S: Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 162: 3749-3752, 1999.
41. Nagai Y, Shimazu R, Ogata H, Akashi S, Sudo K, Yamasaki H, Hayashi S, Iwakura Y, Kimoto M and Miyake K: Requirement for MD-1 in cell surface expression of RP105/CD180 and B-cell responsiveness to lipopolysaccharide. Blood 99: 1699-1705, 2002.
42. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M and Miyake K: Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164: 3471-3475, 2000.
43. Yang H, Young DW, Gusovsky F and Chow JC: Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275: 20861-20866, 2000.
44. Visintin A, Mazzoni A, Spitzer JA and Segal DM: Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci USA 98: 12156-12161, 2001.
45. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, Huber M, Kalis C, Keck S, Galanos C, Freudenberg M and Beutler B: CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565-570, 2005.
46. Godowski PJ: A smooth operator for LPS responses. Nat Immunol 6: 544-546, 2005.
47. Spottl T, Hausmann M, Kreutz M, Peuker A, Vogl D, Scholmerich J, Falk W, Andreesen R, Andus T, Herfarth H and Rogler G: Monocyte differentiation in intestine-like macrophage phenotype induced by epithelial cells. J Leukoc Biol 70: 241-251, 2001.
48. Hausmann M, Bataille F, Spoettl T, Schreiter K, Falk W, Schoelmerich J, Herfarth H and Rogler G: Physiological role of macrophage inflammatory protein-3 alpha induction during maturation of intestinal macrophages. J Immunol 175: 1389-1398, 2005.
49. Austin AS, Judge HM, Robins RA, Cockayne A and Mahida YR: Responses to free lipopolysaccharide and Escherichia coli by normal human intestinal macrophages, following their migration out of the lamina propria. Scand J Immunol 61: 575-584, 2005.
50. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, Kazumori H, Udagawa J, Kadowaki Y and Kinoshita Y: Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol 170: 3977-3985, 2003.
51. Nakata K, Inagawa H, Nishizawa T, Kohchi C and Soma GI: Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages. Clin Exp Immunol 143: 484-493, 2006.
52. Peng Z, Zhang Z and Xu Y: Effect of Angelica sinensis injection on CD11c and CD14 expression in alveolar macrophage membrane of chronic bronchitis patients. Zhongguo Zhong Xi Yi Jie He Za Zhi 19: 282-285, 1999.
53. Hino M, Oda M, Yoshida A, Nakata K, Kohchi C, Nishizawa T, Inagawa H, Hori H, Makino K, Terada H and Soma G: Establishment of an in vitro model using NR8383 cells and Mycobacterium bovis Calmette-Guerin that mimics a chronic infection of Mycobacterium tuberculosis. In Vivo 19: 821-830, 2005.
54. Ogle CK, Wu JZ, Mao X, Szczur K, Alexander JW and Ogle JD: Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation 18: 511-523, 1994.
55. Tschaikowsky K: Protein kinase C inhibitors suppress LPS-induced TNF production in alveolar macrophages and in whole blood: the role of encapsulation into liposomes. Biochim Biophys Acta 1222: 113-121, 1994.
56. Hornef MW, Normark BH, Vandewalle A and Normark S: Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J Exp Med 198: 1225-1235, 2003.
57. Hershberg RM: The epithelial cell cytoskeleton and intracellular trafficking. V. Polarized compartmentalization of antigen processing and Toll-like receptor signaling in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 283: G833-839, 2002.